TG Therapeutics Inc (TGTX)
34.55
+3.40
(+10.91%)
USD |
NASDAQ |
Nov 21, 16:00
36.34
+1.79
(+5.18%)
After-Hours: 06:41
TG Therapeutics Total Liabilities (Quarterly): 393.86M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 393.86M |
June 30, 2024 | 223.64M |
March 31, 2024 | 213.21M |
December 31, 2023 | 169.08M |
September 30, 2023 | 166.30M |
June 30, 2023 | 180.40M |
March 31, 2023 | 169.92M |
December 31, 2022 | 134.98M |
September 30, 2022 | 117.41M |
June 30, 2022 | 122.63M |
March 31, 2022 | 132.64M |
December 31, 2021 | 142.48M |
September 30, 2021 | 98.17M |
June 30, 2021 | 98.27M |
March 31, 2021 | 103.41M |
December 31, 2020 | 106.29M |
September 30, 2020 | 103.20M |
June 30, 2020 | 100.39M |
March 31, 2020 | 103.20M |
December 31, 2019 | 124.40M |
September 30, 2019 | 119.12M |
June 30, 2019 | 93.38M |
March 31, 2019 | 98.28M |
December 31, 2018 | 59.58M |
September 30, 2018 | 42.63M |
Date | Value |
---|---|
June 30, 2018 | 39.34M |
March 31, 2018 | 35.76M |
December 31, 2017 | 30.39M |
September 30, 2017 | 22.24M |
June 30, 2017 | 23.22M |
March 31, 2017 | 22.21M |
December 31, 2016 | 18.91M |
September 30, 2016 | 18.93M |
June 30, 2016 | 16.10M |
March 31, 2016 | 10.62M |
December 31, 2015 | 11.90M |
September 30, 2015 | 11.10M |
June 30, 2015 | 10.66M |
March 31, 2015 | 11.04M |
December 31, 2014 | 6.645M |
September 30, 2014 | 10.46M |
June 30, 2014 | 4.206M |
March 31, 2014 | 3.742M |
December 31, 2013 | 8.058M |
September 30, 2013 | 9.662M |
June 30, 2013 | 7.584M |
March 31, 2013 | 6.688M |
December 31, 2012 | 6.524M |
September 30, 2012 | 7.338M |
June 30, 2012 | 6.744M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
98.17M
Minimum
Sep 2021
393.86M
Maximum
Sep 2024
150.20M
Average
128.52M
Median
Total Liabilities (Quarterly) Benchmarks
ADMA Biologics Inc | 158.73M |
Varex Imaging Corp | 667.80M |
Rhythm Pharmaceuticals Inc | 352.36M |
Inspire Medical Systems Inc | 99.63M |
Mirum Pharmaceuticals Inc | 435.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 586.01M |
Shareholders Equity (Quarterly) | 192.16M |
Debt to Equity Ratio | 1.271 |
Current Ratio | 4.588 |
Net Debt Paydown Yield | -0.80% |